Ultralife (ULBI) Stock Price, News & Analysis

Company Overview

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Ultralife Batteries, Lithium Power, McDowell Research, AMTITM, ABLETM, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, and Criterion Gauge brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.

Key Stats

• Today's Range: $4.78 to $5.21
• 50-Day Range: $4.13 to $6.06
• 52-Week Range: $4.07 to $13.39
• Volume: 67,818 shs
• Average Volume: 70,706 shs
• Market Capitalization: $82.17 million
• P/E Ratio: 8.98
• Dividend Yield: N/A
• Price Target: $14.00
• Consensus Rating: Buy

Ultralife Stock Analysis - MarketRank™

Ultralife scored higher than 62% of companies evaluated by MarketBeat, and ranked 324th out of 655 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Ultralife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Ultralife has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ultralife is 8.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.16.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ultralife is 8.98, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 43.44.

Price to Book Value per Share Ratio

Ultralife has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.77% of the float of Ultralife has been sold short.

Short Interest Ratio / Days to Cover

Ultralife has a short interest ratio ("days to cover") of 4.7.

Change versus previous month

Short interest in Ultralife has recently decreased by 11.52%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ultralife does not currently pay a dividend.

Dividend Growth

Ultralife does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.77% of the float of Ultralife has been sold short.

Short Interest Ratio / Days to Cover

Ultralife has a short interest ratio ("days to cover") of 4.7.

Change versus previous month

Short interest in Ultralife has recently decreased by 11.52%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.0 / 5
• News Sentiment: -0.15

News Sentiment

Ultralife has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Ultralife this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ultralife insiders have not sold or bought any company stock.

Percentage Held by Insiders

39.90% of the stock of Ultralife is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 30.68% of the stock of Ultralife is held by institutions.

ULBI Stock Analysis - Frequently Asked Questions

How have ULBI shares performed this year?

Ultralife's stock was trading at $7.45 at the start of the year. Since then, ULBI stock has decreased by 33.7% and is now trading at $4.94.
View the best growth stocks for 2025 here.

How were Ultralife's earnings last quarter?

Ultralife Co. (NASDAQ:ULBI) announced its quarterly earnings results on Friday, May, 9th. The technology company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.02. Ultralife had a trailing twelve-month return on equity of 7.92% and a net margin of 5.44%.
Read the conference call transcript.

Does Ultralife have any subsidiaries?

The following companies are subsidiaries of Ultralife: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries India Private Limited, Ultralife Batteries (UK) LTD, Ultralife Energy Services Corporation, and Ultralife UK LTD.

Who are Ultralife's major shareholders?

Ultralife's top institutional shareholders include Janney Montgomery Scott LLC (2.65%), Pitti Group Wealth Management LLC (0.13%) and IFP Advisors Inc (0.09%). Insiders that own company stock include Bradford T Whitmore, Thomas Louis Saeli, W Shaw Robert, Michael Edward Manna and Janie Goddard.
View institutional ownership trends.

How do I buy shares of Ultralife?

Shares of ULBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ultralife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ultralife investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Today: 5/09/2025
• Last Earnings: 5/09/2025
• Next Earnings (Estimated): 7/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Miscellaneous electrical machinery, equipment, & supplies
• Sub-Industry: Electrical Equipment
• Current Symbol: NASDAQ:ULBI
• CIK: 875657
• Web: www.ultralifecorporation.com
• Phone: (315) 332-7100
• Fax: 315-331-7800
• Employees: 560
• Year Founded: 1990

Price Target and Rating

• Average Stock Price Target: $14.00
• High Stock Price Target: $14.00
• Low Stock Price Target: $14.00
• Potential Upside/Downside: +183.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.39
• Trailing P/E Ratio: 8.98
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $7.20 million
• Net Margins: 5.44%
• Pretax Margin: 6.61%
• Return on Equity: 7.92%
• Return on Assets: 5.90%

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 3.30
• Quick Ratio: 1.62

Sales & Book Value

• Annual Sales: $164.46 million
• Price / Sales: 0.50
• Cash Flow: $0.55 per share
• Price / Cash Flow: 8.97
• Book Value: $7.68 per share
• Price / Book: 0.64

Miscellaneous

• Outstanding Shares: 16,633,000
• Free Float: 9,993,000
• Market Cap: $82.17 million
• Optionable: Optionable
• Beta: 0.77